A two-test approach for active disease and for previous infection using a sensitive enzyme immunoassay (EIA) or immunofluorescent assay (IFA) followed by a Western immunoblot, Centers for Disease Control and Prevention (CDC), August 11, 1995. | |||||||||
| |||||||||
|
Copyright © 1997-2008 HealthBoard.com